Skip to main content
Starpharma Holdings Limited (ASX:SPL)
Australia flag Australia · Delayed Price · Currency is AUD
0.405
+0.010 (2.53%)
At close: Mar 6, 2026

Starpharma Holdings Revenue

Starpharma Holdings had revenue of 11.16M AUD in the half year ending December 31, 2025, with 39.00% growth. This brings the company's revenue in the last twelve months to 14.58M, up 250.60% year-over-year. In the fiscal year ending June 30, 2025, Starpharma Holdings had annual revenue of 5.85M, down -40.04%.

Revenue (ttm)
14.58M
Revenue Growth
+250.60%
P/S Ratio
11.67
Revenue / Employee
364.45K
Employees
40
Market Cap
170.07M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20255.85M-3.91M-40.04%
Jun 30, 20249.76M5.41M124.64%
Jun 30, 20234.34M-819.00K-15.87%
Jun 30, 20225.16M1.68M48.04%
Jun 30, 20213.49M-3.63M-50.99%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Actinogen Medical 7.36M
Recce Pharmaceuticals 974.56K
Tetratherix 2.00M
Botanix Pharmaceuticals 21.92M
Island Pharmaceuticals 62.85K
Orthocell 9.33M
Paradigm Biopharmaceuticals 8.45K
Dimerix 7.42M
Revenue Rankings

Starpharma Holdings News

More News